MYM Announces Closing of Acquisition of Licensed Producer Highland Grow Inc.

– MYM Nutraceuticals Inc. (CSE:MYM) (CNSX:MYM.CN) (OTC:MYMMF) (“MYM“) is pleased to announce that it has closed the transactions previously announced in its press release dated July 27, 2020, pursuant to which MYM acquired 100% of Biome Grow Inc.’s wholly-owned subsidiary Highland Grow Inc., which is licensed under the Cannabis Act (Canada ) to cultivate, process, and distribute cannabis fromContinue reading “MYM Announces Closing of Acquisition of Licensed Producer Highland Grow Inc.”

Aphria Inc. Announces Strategic Supply Agreement With Canndoc

Aphria now positioned within two of the largest cannabis markets outside of CanadaAgreement with Israeli leader Canndoc provides access to Israel’s largest drugstore chainFinished product will be co-branded under Aphria and Canndoc brands  – Aphria Inc. (“Aphria” or the “Company“) (TSX: APHA) and (NASDAQ: APHA), a leading global cannabis company, today announced it has entered into a Strategic Supply Agreement (the “Agreement”) with Canndoc Ltd. (“Canndoc“), aContinue reading “Aphria Inc. Announces Strategic Supply Agreement With Canndoc”

Village Farms International Partners with One of Asia-Pacific’s Leading Cannabinoid Platforms, Altum International, to Target Asia-Pacific CBD and Cannabis Markets

– Village Farms International, Inc. (“Village Farms” or the “Company”) (NASDAQ: VFF) (TSX: VFF) today announced that it has executed a binding agreement (“the Agreement”) to acquire 6.6% of Australia-based Altum International Pty Ltd (“Altum”), one of the Asia-Pacific’s leading cannabinoid platforms, subject to the completion of certain conditions, which are expected to be finalized in the next several weeks. Continue reading “Village Farms International Partners with One of Asia-Pacific’s Leading Cannabinoid Platforms, Altum International, to Target Asia-Pacific CBD and Cannabis Markets”

MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors

— MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the appointment of Chris Halyk – former President of Janssen Inc. (Canada), one of the Janssen Pharmaceutical Companies of Johnson & Johnson – to its Board of Directors,Continue reading “MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors”

Halo Announces Closing of Acquisition of Outer Galactic Chocolates, a Type N License Holder in California. Plans California Edibles Launch by September.

All figures in USD unless stated otherwise –Halo Labs Inc. (“Halo” or the “Company”) (NEO: HALO, OTCQX: AGEEF, Germany: A9KN) is pleased to announce that, further to its press release dated January 15, 2020, it has closed its acquisition of Outer Galactic Chocolates, LLC (“OGC”), holder of a Type N manufacturing license in Mendocino County.Continue reading “Halo Announces Closing of Acquisition of Outer Galactic Chocolates, a Type N License Holder in California. Plans California Edibles Launch by September.”

Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains – The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit)

Company investing in new genetics, and micropropagation with Segra as part of its commitment to continuous improvement in product quality –(BUSINESS WIRE)–Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “Company” or “Organigram”), a leading licensed producer of cannabis, is pleased to announce the launch of three new strains of EdisonContinue reading “Organigram Strengthens Edison Flower Portfolio with Three New High Potency Strains – The General (Grapefruit GG4), Chemdog and Samurai Spy (Ninja Fruit)”

iAnthus Reports Fiscal 2019 Financial Results and Provides Additional Business Updates

– iAnthus Capital Holdings, Inc. (“iAnthus” or the “Company”) (CSE: IAN) (OTCQX: ITHUF), which owns, operates, and partners with regulated cannabis operations across the United States, reports its financial results for the year ended December 31, 2019. The Company’s Financial Statements for the year ended December 31, 2019 and the related Management’s Discussion & Analysis can be accessed on the Company’s SEDAR profileContinue reading “iAnthus Reports Fiscal 2019 Financial Results and Provides Additional Business Updates”

FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease

— Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older. Epidiolex was previously approved for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome (LGS) andContinue reading “FDA Approves New Indication for Drug Containing an Active Ingredient Derived from Cannabis to Treat Seizures in Rare Genetic Disease”